Skip to content
Search AI Powered

Latest Stories

Reuben McDaniel Resigns from New York's Cannabis Control Board Amid Conflict of Interest Controversy

DASNY president Reuben McDaniel resigns from Cannabis Control Board
DASNY president Reuben McDaniel resigns from Cannabis Control Board
Credit: JOHNNY CRAWFORD / JCRAWFORD@AJC.COM

Reuben McDaniel, a member of the New York Cannabis Control Board (CCB), has stepped down from his position following mounting criticism over allegations of a conflict of interest. McDaniel, who also serves as the president of the Dormitory Authority of the State of New York (DASNY), tendered his resignation during Thursday's CCB meeting.

During the meeting, McDaniel expressed his gratitude for the opportunity to serve on the board and commended Governor Kathy Hochul's vision for advancing cannabis social equity in the state. However, he did not disclose the specific reasons for his departure. CCB Chairwoman Tremaine Wright thanked McDaniel for his service and expressed the board's continued collaboration on the social equity fund.


Former Governor Andrew Cuomo had recommended McDaniel for the presidency of DASNY in 2019, and Governor Hochul appointed him to the five-member CCB in September 2021. However, concerns regarding McDaniel's dual roles have been raised by industry stakeholders. DASNY plays a crucial role in the marketplace rollout, while the Office of Cannabis Management (OCM), which McDaniel oversaw as a CCB board member, has a distinct focus on equity.

The OCM, in its early stages, had developed the Conditional Adult-Use Retail Dispensary (CAURD) program from within DASNY's offices, leading to DASNY's significant involvement in launching the program. This involvement included securing real estate for retailers, finding a fund manager to raise $150 million, and identifying a financial institution for banking services. However, as challenges arose within the CAURD program, such as difficulties in securing real estate and insufficient funding, criticism was directed at DASNY and McDaniel.

Industry stakeholders, including the Cannabis Association of New York, have questioned the potential conflict of interest arising from McDaniel's simultaneous positions. Licensed retailers, in particular, have called for transparency and accountability from DASNY. Some CAURD applicants have accused DASNY of pressuring them into overpriced dispensary locations and providing inflated contractor bids without disclosing loan terms.

Despite his resignation from the CCB, McDaniel will continue to serve as DASNY's president, and the organization will maintain its role in developing New York's cannabis marketplace.

More For You

gif of actor Kevin James from King of Queens; asking "How Much Does That Cost?"
Why Is Some Weed More Expensive Than Others? Understanding Cannabis Pricing
Giphy

Unraveling Cannabis Pricing: Factors Behind the Cost of Weed


Step inside a cannabis dispensary for the first time and the experience can be overwhelming. The meticulously labeled glass jars showcase dozens of strains with names like "Wedding Cake" and "Blue Dream," while refrigerated cases display concentrates, edibles, and tinctures at wildly different price points. Unlike the days when consumers were limited to whatever their neighborhood dealer offered, today's legal market presents a dazzling array of options that might leave newcomers with both wonder and sticker shock.

Keep ReadingShow less
Comprehensive Glossary of Cannabis Terminology - The Bluntness
Cannabis Terminology - The Bluntness
Photo by Margo Amala on Unsplash

Are You Ready to Master Cannabis Lingo? Explore Essential Terms Now

This glossary covers key cannabis-related terms that can help consumers better understand the cannabis industry, products, and their effects. Whether you're new to cannabis or looking to deepen your knowledge, these definitions offer clarity on common terms you might encounter.

Cannabis Basics: What is Cannabis?

Cannabis is a fascinating plant species that includes three main types: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Each of these species has unique characteristics and effects. The cannabis plant is a complex organism, rich in various compounds such as cannabinoids, terpenes, and flavonoids. These compounds contribute to the plant’s diverse range of effects and therapeutic benefits. Cannabis plants are cultivated for both medicinal and recreational purposes, and they can be consumed in multiple forms, including dried flower, extracts, and edibles. Whether you’re interested in the energizing effects of Cannabis sativa, the relaxing properties of Cannabis indica, or the unique traits of Cannabis ruderalis, there’s a cannabis plant to suit every need.

Cannabis Products: Cannabis Extracts

Cannabis extracts are highly potent products derived from the cannabis plant using various extraction methods, such as solvents or CO2. These extracts are concentrated forms of cannabis that can be used in several ways, including dabbing, vaporizing, or as ingredients in edibles and topicals. There are several types of cannabis extracts, each with its own texture and potency, including wax, shatter, oil, and crumble. These products are often favored for their high cannabinoid content and are commonly used for medicinal purposes, such as pain relief and anxiety management. Whether you’re looking for a powerful dabbing experience or a potent ingredient for your homemade edibles, cannabis extracts offer a versatile and effective option.

Keep ReadingShow less
retail shelves stocked with legal cannabis products
The mix of in-state and out of state brands at a legal NY dispensary
The mix of in-state and out of state brands at a legal NY dispensary

NY's Pot Industry: Wins, Woes, Next

Two years into New York's adult-use cannabis rollout, the state's Office of Cannabis Management (OCM) has dropped its most comprehensive look yet at the market's performance, challenges, and opportunities. The 2024 OCM Market Report is packed with impressive numbers and lofty intentions, but peel back the layers and a more complicated story unfolds—one where equity goals face harsh economic headwinds, regulatory delays hamper progress, and a persistent illicit market looms large.

Here's what you need to know:

Keep ReadingShow less
map of medical and recreational cannabis retailers in state of New York
NY Cannabis Program Under Fire for Misconduct
NY Cannabis Program Under Fire for Misconduct

Legal Weed, Legit?

New York’s legal cannabis industry was supposed to be the nation’s model of equity and regulation. Instead, it’s quickly becoming a cautionary tale. And the latest news doesn’t just raise eyebrows—it should set off alarms across the entire industry.

According to an April 7 report by The New York Times, New York State regulators are conducting a sweeping investigation into some of the biggest cannabis companies operating in the state—Stiiizy, Grön, Mfused, and others—over allegations of using out-of-state or unauthorized cannabis to produce products for legal dispensaries. It’s a practice insiders call inversion—and it’s been the industry’s not-so-secret open secret for years.

Keep ReadingShow less
U.S. States with highest revenue from cannabis taxes
U.S. States with highest revenue from cannabis taxes

U.S. States with the Highest Revenue from Cannabis Taxes

The Drug Enforcement Agency (DEA) hasn't seen any reason to remove cannabis from its list of Schedule I banned substances. Yet, cannabis in its myriad forms is pulling in billions of dollars in vital tax revenue for those states where it is legal —$3 billion in 2022 alone.

The drug has sat in the Schedule I classification alongside heroin, peyote, and other substances the DEA considers to have a high potential for abuse since 1970, when Congress enacted the Controlled Substances Act, making it federally illegal to possess them. Two decades after the law passed, following intense social pressure that segued into the realization of a new tax opportunity, certain states began to make the drug available to residents, citing the medical benefits and relative safety compared with other substances

Keep ReadingShow less